About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Rheumatology Research Group (GRR) is focused on translational research in immunity-mediated inflammatory diseases (IMIDA), mainly in the area of rheumatology. The GRR is a multidisciplinary group made up of clinical specialists, biologists, bioinformaticians and laboratory technicians. The different research lines of the GRR emphasize the use of high-performance technologies for the study at the cellular and molecular level of the immununopathology of IMIDA, mainly chronic inflammatory arthritis and autoimmune systemic diseases.
At the clinical level, we have developed lines of research in very diverse areas of rheumatology, including chronic inflammatory arthritis (rheumatoid arthritis, spondyloarthropathies), systemic autoimmune diseases (lupus, myositis, Sjögren's syndrome), the study of musculoskeletal imaging, pediatric rheumatology (juvenile idiopathic arthritis, autoimmune systemic diseases, autoinflammatory syndromes), central sensitization syndromes and the study of bone metabolism. One of the main objectives of the GRR is the coordination of basic and clinical research to accelerate the transfer of knowledge to clinical practice and thus improve the quality of life of patients.
IP: Sara Marsal Barril Collaborators: Antonio Julia Cano, Javier Hoyo Pérez, Elena Granell Pallares, Adria Aterido Ballonga Funding agency: EUROPEAN COMMISSION Funding: 1079085 Reference: DOCTIS_H2020_SC1-BHC2019 Duration: 01/01/2020 - 31/12/2025
IP: Sara Marsal Barril Collaborators: Nuria Palau Balaña, Luis Riera Soler, Estefania Moreno Ruzafa, Mireia Lopez Corbeto, Adria Aterido Ballonga Funding agency: Instituto de Salud Carlos III Funding: 208120 Reference: PI19/00225 Duration: 01/01/2020 - 30/06/2024
IP: José Alegre Martin Collaborators: Jesus Castro Marrero Funding agency: Instituto de Salud Carlos III Funding: 87120 Reference: PI19/00629 Duration: 01/01/2020 - 30/06/2024
IP: Josefina Cortes Hernandez Collaborators: Teresa Moline Marimon, Sheila Bermejo Garcia Funding agency: Instituto de Salud Carlos III Funding: 141570 Reference: PI21/00287 Duration: 01/01/2022 - 31/12/2024
PMID: 37935561 Journal: Year: 2023 Reference: Open Heart. 2023 Nov;10(2):e002431. doi: 10.1136/openhrt-2023-002431. Impact factor: Publication type: Paper in international publication Authors: Aguade-Bruix, Santiago; Aterido, A; Carrascosa-Carrillo, J M; Ferreira Gonzalez, Ignacio; Guillen, Y; Julia, A; Li, T; Marsal, S; Martinez, S; Romero-Farina, Guillermo et al. DOI: 10.1136/openhrt-2023-002431
PMID: 37960157 Journal: Nutrients Year: 2023 Reference: Nutrients. 2023 Oct 24;15(21):4504. doi: 10.3390/nu15214504. Impact factor: Publication type: Paper in international publication Authors: Alegre-Martin, Jose; Awad, Mark M; Castro-Marrero, Jesus; Cheema, Parneet K; Csoszi, Tibor; Gottfried, Maya; Gumus, Mahmut; Jurek, Joanna; Kalemkerian, Gregory P; Kato, Terufumi et al. DOI: 10.3390/nu15214504
PMID: 37976444 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2023 Reference: J Clin Oncol. 2023 Nov 17:JCO2301363. doi: 10.1200/JCO.23.01363. Impact factor: Publication type: Paper in international publication Authors: Alegre-Martin, Jose; Bryl, Maciej; Castro-Marrero, Jesus; Chiu, Chao-Hua; Dumoulin, Daphne W; Hoang, Tien; Hong, Min Hee; Huang, Meilin; Johnson, Melissa; Jurek, Joanna et al. DOI: 10.1200/JCO.23.01363
PMID: 37995294 Journal: RHEUMATOLOGY Year: 2023 Reference: Rheumatology (Oxford). 2023 Nov 23:kead614. doi: 10.1093/rheumatology/kead614. Impact factor: Publication type: Paper in international publication Authors: Blasi, Joan; Bong, David A; Chu, Winnie C; Concepcion, Nathan David P; Coronel, Luis; D'Agostino, Maria Antonietta; Daltro, Pedro; DiPrete, Olivia; Garcia-Pena, Pilar; Kasznia-Brown, Joanna et al. DOI: 10.1093/rheumatology/kead614
The head of the Rheumatology Service at Vall d'Hebron University Hospital and of the Rheumatology research group at VHIR is a highly accomplished rheumatologist with a distinguished career in the field.
It is the first international multi-centre clinical trial to analyse the safety and effect of this treatment for an autoimmune disease.
Els estudis avançaran en els camps de les malalties digestives, el VIH, la fatiga crònica, les patologies cardíaques, l’hepatitis, la diabetis i l’oftalmologia.
